Prescient Therapeutics LimitedASX: PTX

US FDA allows PTX-100 Ph2 trial

Dec 23, 2024 at 3:47 AM UTC · Issued by Prescient Therapeutics Limited

Prescient Therapeutics Ltd has released a press release.

View Attachment